These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2488281)

  • 1. Treatment dilemmas for HIV infected haemophiliacs.
    Lee CA; Miller R; Goldman E
    AIDS Care; 1989; 1(2):153-8. PubMed ID: 2488281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating HIV positive haemophiliacs with zidovudine.
    BMJ; 1988 Dec; 297(6663):1608-9. PubMed ID: 3147094
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating HIV positive haemophiliacs with zidovudine.
    Aronstam A
    BMJ; 1988 Nov; 297(6659):1331. PubMed ID: 3144380
    [No Abstract]   [Full Text] [Related]  

  • 4. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [20-year-old HIV-1-positive hemophiliac patient with conspicuous plantar warts--effects of zidovudine (Retrovir) treatment].
    Muntean W; Zenz W
    Wien Klin Wochenschr; 1990 Aug; 102(16):486-9. PubMed ID: 2219942
    [No Abstract]   [Full Text] [Related]  

  • 6. Bleeding episodes in HIV-positive patients taking HIV protease inhibitors: a case series.
    Racoosin JA; Kessler CM
    Haemophilia; 1999 Jul; 5(4):266-9. PubMed ID: 10469181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nail pigmentation caused by azidothymidine].
    Depaoli MA; Bedello PG; Tamponi M
    G Ital Dermatol Venereol; 1989 Mar; 124(3):71-2. PubMed ID: 2807386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group.
    Koch MA; Volberding PA; Lagakos SW; Booth DK; Pettinelli C; Myers MW
    Arch Intern Med; 1992 Nov; 152(11):2286-92. PubMed ID: 1359846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progression to AIDS among HIV-seropositive hemophiliacs].
    Lorenzo JI; Molina R; Senent ML; Monzó E; Lerma MA; Dasí MA; Monteagudo E; Aznar JA
    Sangre (Barc); 1992 Jun; 37(3):169-74. PubMed ID: 1440093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies.
    Arcieri R; Puopolo M; Baudo F; Chiarotti F; De Rosa V; Schinaia N; Mori PG; Ghirardini A
    Haematologica; 1995; 80(1):25-30. PubMed ID: 7758987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine overdose in an asymptomatic HIV seropositive patient with hemophilia.
    Stern RA; van der Horst CM; Hooper SR; Bloodgood KM; High KA
    Psychosomatics; 1992; 33(4):454-7. PubMed ID: 1461972
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment.
    Bratt G; Eriksson LE; Sandström E; Gilljam G; Hinkula J; Albert J; Redfield R; Wahren B
    Int J STD AIDS; 1999 Aug; 10(8):514-21. PubMed ID: 10471100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC; Nielsen C; Gerstoft J; Nielsen CM; Vestergaard BF
    Ugeskr Laeger; 1994 Jan; 156(2):185-6. PubMed ID: 7905217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of HIV-positive women toward zidovudine therapy during pregnancy.
    J Adv Nurs; 2002 Sep; 39(5):410-1. PubMed ID: 12229862
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine for symptomless HIV infection.
    Lancet; 1990 Apr; 335(8693):821-2. PubMed ID: 1969561
    [No Abstract]   [Full Text] [Related]  

  • 17. [AIDS. Trial with Retrovir for HIV-positive subjects].
    Vesterdal A
    Sygeplejersken; 1989 May; 89(18):10-3. PubMed ID: 2669201
    [No Abstract]   [Full Text] [Related]  

  • 18. Zidovudine treatment for anti-HIV positive haemophiliacs.
    Lim SG; Lee CA; Kernoff PB
    Clin Lab Haematol; 1990; 12(4):367-78. PubMed ID: 2081377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
    Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
    N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients.
    Gartland M;
    Antivir Ther; 2001 Jun; 6(2):127-34. PubMed ID: 11491417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.